Foster & Motley Inc. Cuts Stake in McKesson Corporation $MCK

Key Points

• Foster & Motley Inc. reduced its stake in McKesson by 9.0%, selling 1,356 shares and finishing the quarter with 13,753 shares valued at about $11.282 million.
• McKesson beat estimates with $9.34 EPS vs. $9.19 and revenue of $106.16 billion (up 11.4% YoY), and issued FY2026 guidance of $38.80–$39.20 EPS while analysts' consensus target is roughly $960.93.
• The company declared a quarterly dividend of $0.82 (annualized $3.28, yield 0.4%, ex-dividend March 2) and insiders have sold about 3,868 shares worth approximately $3.74 million in the past 90 days.

Foster & Motley Inc. reduced its position in McKesson Corporation (NYSE:MCK - Free Report) by 9.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,753 shares of the company's stock after selling 1,356 shares during the period. Foster & Motley Inc.'s holdings in McKesson were worth $11,282,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the business. GGM Financials LLC purchased a new position in shares of McKesson during the 3rd quarter worth about $25,000. State of Wyoming bought a new stake in McKesson during the 2nd quarter valued at about $29,000. Hopwood Financial Services Inc. purchased a new stake in McKesson in the 3rd quarter valued at about $31,000. Vermillion & White Wealth Management Group LLC bought a new position in McKesson in the 3rd quarter worth about $33,000. Finally, Board of the Pension Protection Fund purchased a new position in shares of McKesson during the fourth quarter worth approximately $33,000. Institutional investors own 85.07% of the company's stock.

McKesson Price Performance

Shares of MCK stock opened at $860.37 on Tuesday. The company has a market cap of $105.39 billion, a price-to-earnings ratio of 24.74, a PEG ratio of 1.38 and a beta of 0.38. McKesson Corporation has a 1-year low of $637.00 and a 1-year high of $999.00. The stock has a 50 day simple moving average of $908.02 and a 200-day simple moving average of $841.69.

McKesson (NYSE:MCK - Get Free Report) last released its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating the consensus estimate of $9.19 by $0.15. The business had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business's quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter last year, the business posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson's payout ratio is 9.43%.

Insiders Place Their Bets

In related news, EVP Michele Lau sold 2,725 shares of the business's stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the sale, the executive vice president owned 3,247 shares in the company, valued at approximately $3,214,530. The trade was a 45.63% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Leann B. Smith sold 190 shares of the firm's stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the transaction, the executive vice president owned 2,989 shares of the company's stock, valued at $2,824,605. This trade represents a 5.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 3,868 shares of company stock worth $3,743,820. Insiders own 0.08% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. TD Cowen boosted their price target on McKesson from $1,000.00 to $1,012.00 and gave the company a "buy" rating in a report on Thursday, February 5th. Raymond James Financial set a $970.00 price objective on McKesson in a research report on Thursday, March 5th. Leerink Partners reiterated an "outperform" rating and issued a $1,085.00 target price on shares of McKesson in a report on Thursday, March 5th. JPMorgan Chase & Co. upped their price target on McKesson from $983.00 to $1,107.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 10th. Finally, Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of McKesson in a report on Wednesday, December 10th. Thirteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, McKesson currently has an average rating of "Moderate Buy" and a consensus target price of $960.93.

McKesson Company Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.